ϸ°ûÉúÎïѧ£º !!1?2ine
Ò»¡¢ Ãû´Ê½âÊÍ£º lYx_8x2
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© ANhtz1Fl
2£® PCR£¨96£©
?.?)5
&4
3£® ·ºËØ£¨ubquitin£©£¨96£© Js,! G
4£® °é·Ö×Ó£¨chapron£©£¨96£© ;>J!$B?,
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© (0$~T}lH
6£® DG£IP3£¨96£© T`bYidA
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© Z,).)y#B
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© rQjk
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© 5p0~AN)
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© Q]k<Y
11£® Transformation£¨92£© cI=6zMB
12£® TransfectionתȾ£¨92£© OdzeHpH3g
13£® Transcytosis×ªÒÆ×÷Óã¨92£© 9p{4-]
14£® Transductionתµ¼£¨92£© ?XBdBR_"^
15£® Transdetermination£¨92£© X{-4w([
16£® Transdifferentiation£¨92£© NdXHpq;
17£® Transgenic animalת»ùÒò¶¯Î92£© 8?yIixhw
18£® Rb£1£¨92£© h[
.
19£® P53£¨92¡¢91£© e=s
c$1|4=
20£® C£jun£¨92£© }je<^]a
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© -$d?e%}#
22£® °ûÄÚÌ壨99£© voa)V1A/]
23£® Cyclin dependent kinase inhibitor(CDKI)(99) 5GsmBf$RUb
24£® G£protein£¨91£© 7+jxf[(XQ
25£® Restriction point£¨91£© ng1E'c]0@
26£® Antipost£¨91£© "- 4|HA
27£® Capping£¨91£© |+c
z\+
28£® TATAbox£¨91£© <y6`8J7:
29£® cDNA library£¨90£© km%r{
30£® Aritotic apparatus£¨90£© QQJGqM3a2
31£® ¿çĤÐźŠtransmembrane signal£¨90£© k[Em~>m
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© X5)D [aE6
33£® Nuclear lamina£¨90£© K;
#FU
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© }+
,Q&]>~
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© 1iT_mtXK$
36£® ϸ°û·Ö»¯£¨00£© Jf^3nBZ
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© RD`|Z~:q:K
38£® ¿Ë¡£¨00£© YU,zQ V'
39£® »ùÒò×飨00£© </I%VHP,[f
40£® Caspase£¨00£© :5kDc"
=Z|
41£® ת¼Òò×Ó£¨00£© 7K"3[.
42£® ÅßÌ¥¸Éϸ°û£¨01£© ]3,'U(!+
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© Qf:e;1F!
44£® DNAоƬ£¨01£© }?m0bM
¶þ¡¢ ÎÊ´ðÌ⣺ g@H<Q('fJ
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© Y.m1d ?H 1
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© htB2?%S=T
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© Bc=(1ty)
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© Zg+.`>z
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© _`2%)#^o
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© p{E(RsA
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© w,1N ;R&
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© d V%
o:@Z
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© :(q4y-o6
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© |gkNhxzB
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© +Xg:*b9So
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© yzEyOz@Q
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© F=F84_+K
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© ?>7\L'n=5I
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© bK "I
9T #
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© sI\NX$M
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© CH7a4qL`
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© f@sC~A. 9\
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© V@0T&#
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© WrP
+n
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© %LnLB
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© .BxI~d^
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© 9@1n:X
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© Ry[7PLn]
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© Qi\]='C
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© wQW`Er3w
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© ;)ay uS sQ
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© /yU#UZ4;
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© {]Mwuqn
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© a@g
<cl7a,
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© .XpuD,^;@
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© N5 sR
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© pI f6RwH}%
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© 548L^"D
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©